Phreesia Stock Intrinsic Value – Phreesia Maintains ‘Buy’ Rating As Business Shifts to Profitable Growth
☀️Trending News Phreesia ($NYSE:PHR), a healthcare technology company that provides solutions for patient intake and engagement, has recently earned a [...]
Phreesia Stock Intrinsic Value – Phreesia’s Q1 Results Outperform Expectations with GAAP EPS of -$0.58 and Revenue of $91.62M
🌥️Trending News In addition, Phreesia ($NYSE:PHR) reported revenue of $91.62M, surpassing analyst projections by $1.82M. The company's products range from [...]
Phreesia Intrinsic Value – Phreesia Adds PAM Measure to Medicare Incentive System
☀️Trending News Phreesia ($NYSE:PHR), a leading healthcare technology company, has recently announced that it has added the Patient Activation Measure [...]
Phreesia Stock Fair Value – PHREESIA Reports Strong Earnings for Second Quarter of FY2024
☀️Earnings Overview On July 31, 2023, PHREESIA ($NYSE:PHR) released their financial results for the second quarter of Fiscal Year 2024. [...]
Phreesia Stock Fair Value – Phreesia’s FQ1 Results Exceed Expectations, Company Reaffirms 2024 Revenue Guidance
🌥️Trending News Phreesia ($NYSE:PHR), a healthcare technology company, recently announced its first-quarter financial results, which exceeded expectations. This reflects the [...]
Phreesia Set to Report Q1 2023 Earnings: A Deep Dive into the Data
🌥️It’s that time again when investors and financial analysts eagerly anticipate the earnings report of Phreesia (PHR), the healthcare software-as-a-service [...]
Phreesia’s Share Price Reflects Positive Investor Sentiment
Trending News ☀️ Phreesia ($NYSE:PHR), Inc., is a healthcare software company that provides innovative patient intake technologies to streamline the [...]
Keybank National Association OH Boosts Investment in Phreesia, During Q4
Trending News ☀️ By utilizing their cloud-based platform, healthcare providers can streamline their operations and improve patient satisfaction. This move [...]
Guggenheim Raises Price Target on Phreesia Stock to $40, Maintains Buy Rating
Trending News 🌥️ Guggenheim recently raised its Price Target on Phreesia ($NYSE:PHR) stock to $40, while maintaining its Buy Rating. [...]
Phreesia’s Alexandra Beneville Recognized as One of MM+M’s ‘Women to Watch’ in 2023.
Trending News 🌥️ Phreesia ($NYSE:PHR) is proud to announce that Vice President, Life Sciences Content Strategy, Alexandra Beneville was recently [...]
